41
Sample & Assay Technologies Zhong Wu, Ph.D. R&D Scientist Wnt Signaling: a case study with new research solution

Wnt part ii 2013

Embed Size (px)

Citation preview

Page 1: Wnt part ii 2013

Sample & Assay Technologies

Zhong Wu, Ph.D.R&D Scientist

Wnt Signaling: a case study with new research solution

Page 2: Wnt part ii 2013

Sample & Assay Technologies

Topics to cover

�Overview of Wnt signaling

� Function of Wnt signaling

�Research tools to study Wnt signaling

Page 3: Wnt part ii 2013

Sample & Assay Technologies

Topics to cover

�Overview of Wnt signaling�Wnt discovery and family members�Canonical�Noncanonical

� Function of Wnt signaling

�Research tools to study Wnt signaling

Page 4: Wnt part ii 2013

Sample & Assay Technologies

Wnts and receptors

� Discovery of Wnt� Murine oncogene Int-1� Homolog to Drosophila segment polarity gene Wingless

� Wnt proteins� 19 members� Highly conserved� Secreted glycoproteins� Activate cell surface receptors

� Wnt receptors� FZD/LRP receptor complex� 10 members of FZD� LRP5 and LRP6 coreceptor

Page 5: Wnt part ii 2013

Sample & Assay Technologies

Different Wnt signaling pathways

Sci. Signal. 1, re9 (2008)

Page 6: Wnt part ii 2013

Sample & Assay Technologies

Canonical Wnt pathway

Nat Rev Cancer. 2008;8:387-98

Page 7: Wnt part ii 2013

Sample & Assay Technologies

Noncanonical Wnt pathway

Nat Rev Neurosci. 2010;11(2):77-86

Wnt/JNK Wnt/calcium

Cell polarization in epithelial sheetPolarized cell movementsLarger overlap with Wnt/PCP

Cell adhesionCardiac differentiationGene expression through NFAT, HDAC

CN

Page 8: Wnt part ii 2013

Sample & Assay Technologies

What dictates different Wnt pathways?

�Different Wnt proteins�Wnt1,Wnt3A, Wnt8 - canonical�Wnt5A, Wnt11 - noncanonical

�Receptor mediated�Wnt/Frizzled/LRP – β-catenin signaling�Frizzled – PCP and Ca2+ signaling�Wnt/Ryk – Src signaling�Wnt/Ror2 – JNK signaling

Sci. Signal. 1, re9 (2008)

Page 9: Wnt part ii 2013

Sample & Assay Technologies

Topics to cover

�Overview of Wnt signaling�Wnt discovery and family members�Canonical�Noncanonical

� Function of Wnt signaling�Development�Tissue homeostasis�Pathological condition

�Research tools to study Wnt signaling

Page 10: Wnt part ii 2013

Sample & Assay Technologies

Wnt signaling in embryonic development

� Cell fate determination

� Proliferation

� Migration, motility and polarity specification

� Tissue patterning

� Organogenesis and organization of the body plan

� Almost every development process� Axial formation� Mesoderm specification� Production of presomitic mesoderm� Direct patterning of the nervous system� Suppress chondrogenic potential of joint interzone cells

Page 11: Wnt part ii 2013

Sample & Assay Technologies

Wnt signaling in tissue renewal

Nature 434, 843-850 (2005) & Development 134, 479-489 (2007)

� Zebrafish tail fin and heart regeneration

�Maintain stem-cell like fate � Intestinal epithelium� Skin� Hematopoietic cells� Neural stem cells

Page 12: Wnt part ii 2013

Sample & Assay Technologies

Wnt signaling in developmental malformation

Development cell 17,9-26 (2009)

Page 13: Wnt part ii 2013

Sample & Assay Technologies

Wnt signaling in cancer

Eur J Cancer 45,2709-2769 (2009), Nature 434, 843-850 (2005) & Wnt homepage

Page 14: Wnt part ii 2013

Sample & Assay Technologies

Wnt signaling in CNS -related diseases

� Alzheimer’s disease� Reduced β-catenin signaling� Tau hyperphosphorylation by GSK3β� LRP6 association

� Parkinson’s disease� Wnt-β-catenin and Wnt-PCP� Dopaminergic development and neurogenesis

� Schizophrenia� Wnt1 overexpression� SNPs in FZ3� DISC1 interacts with GSK3β

Nat Rev Neurosci. 2010;11(2):77-86

Page 15: Wnt part ii 2013

Sample & Assay Technologies

Wnt signaling in other pathological condition

� High bone mass and Osteoporosis� LRP5 activating (LRP5G171V) � LRP5 lose of function mutation

� Type II diabetes� Wnt5B� TCF7L2 (TCF4)

� Pulmonary fibrosis� Activated β-catenin signaling

N Engl J Med 2002;346:1513-1521, Am J Hum Genet, 2004,75:832-43

Page 16: Wnt part ii 2013

Sample & Assay Technologies

Topics to cover

� Overview of Wnt signaling� Wnt discovery and family members� Canonical� Noncanonical

� Function of Wnt signaling� Development� Tissue homeostasis� Pathological condition

� Research tools to study Wnt signaling – A real case study about Wnt pathway activity

Page 17: Wnt part ii 2013

Sample & Assay Technologies

Study Wnt pathway activity

� Why Wnt pathway activity� Involving in many physiological and pathological process� Mutations of Wnt components lead to altered pathway activity

� Current methods to study Wnt pathway activity� β-catenin translocation� Reporter assay� Wnt target genes� Western blot of active β-catenin

Page 18: Wnt part ii 2013

Sample & Assay Technologies

Cignal reporter from SABiosciences

� Two modality� Dual luciferase� GFP

� Two systems� Plasmid� Lenti

� Over 40 pathways� Wnt and more

Page 19: Wnt part ii 2013

Sample & Assay Technologies

Reporter assay vs Wnt target genes

� Reporter assay� Relatively simple� High throughput� Rely on TRE� Possible disconnection from endogenous gene expression

� Wnt target genes?� Endogenous genes� Readout based on multiple genes� No quantification as a whole set

Quantitative Wnt target genes? – Develop Wnt gene expression signature with companion scoring

Page 20: Wnt part ii 2013

Sample & Assay Technologies

Proposed work flow for Wnt gene expression signature development

1 or 2 cell linesstimulation

inhibition

~ 20 cell lines

Microarray

Initial list ofResponse genes

Expanded dataset

Real-time PCRInitial gene list

Mathematic model classification

Small subset ofsignature genes

signature genesensitivity

Compare to otherpathway activity readout

Page 21: Wnt part ii 2013

Sample & Assay Technologies

Experiment setup for whole genome gene expression profiling

� Whole genome gene expression profiling after altering Wnt/β-catenin pathway activity� Illumina bead chip by SABio Service Core

� Treatment � Stimulation – Wnt3a� Inhibition – siRNA for β-catenin (Qiagen FlexiTube siRNA)

� Wnt Pathway activity readout � Wnt target genes (Wnt signaling target PCR array)� Active β-catenin protein levels

� Cell lines � 293H� FHC

Page 22: Wnt part ii 2013

Sample & Assay Technologies

SABiosciences service core

� Whole genome� Illumina expression profiling� Illumina genotyping

� Pathway/focused panel� Mutation profiling� Methylation� PCR array� miRNA PCR array

� Individual gene/Locus� Mutation� Methylation� qRT-PCR SYBR Green

� Sample prep� Cell, tissue or biofluids� Fixed tissue

Complete service for genomic and expression analysi s that delivers robust and reproducible results.

Page 23: Wnt part ii 2013

Sample & Assay Technologies

Complete solution for gene silencing from QIAGEN

� Predesigned siRNA � FlexiTube siRNA or siRNA Premix� FlexiPlate siRNA� QIAGEN AllStars RNAi controls

� Custom siRNA synthesis� HP Custom siRNA – 20 nmol

� Plasmid based RNAi� SureSilencing shRNA plasmids

� Transfection reagents� HiPerFect transfection reagent� HiPerFect HTS reagent� FlexiTube siRNA Premix

� siRNA/DNA cotransfection� Attractene Transfection Reagent

Page 24: Wnt part ii 2013

Sample & Assay Technologies

ββββ-catenin targeted siRNA from QIAGEN

Page 25: Wnt part ii 2013

Sample & Assay Technologies

Experiment setup for whole genome gene expression profiling

� Whole genome gene expression profiling after altering wnt/β-catenin pathway activity� Illumina bead chip service by SABio Service Core

� Treatment � Stimulation – Wnt3a� Inhibition – siRNA (Qiagen flexible tube siRNA)

� Wnt Pathway activity readout � Wnt target genes (Wnt signaling target PCR array)� Active β-catenin protein levels

� Cell lines � 293H� FHC

Page 26: Wnt part ii 2013

Sample & Assay Technologies

What is Wnt signaling target PCR Array?

• 84 genes responsive to Wnt pathway transduction

• 5 Housekeeping Genes

• Genomic DNA Contamination Control

• Reverse Transcription Controls (RTC) n=3

• Positive PCR Controls (PPC) n=3

Supported PCR Array Formats• 96-Well Plate• 384-Well Plate• 100-Well Disc• 96x96 Chip

Over 100 different pathways available!

Page 27: Wnt part ii 2013

Sample & Assay Technologies

Gene content on Wnt signaling target PCR Array

Page 28: Wnt part ii 2013

Sample & Assay Technologies

RT2 PCR Arrays Work Flow

•cDNA Synthesis (C-03 kit)– Genomic DNA Removal Step (5 min.)– Reverse Transcription Step (20 min.)

•Load Plates – 1 Sample per PCR Array– 2 minutes with multi-channel pipet

•Run 40 cycle qPCR Program – Standard cycling conditions for all

Real Time PCR Instruments– 2 hours

•Upload and Analyze Data (FREE)– 15 minutes from Raw Ct to Fold Change Data

control experimental

Page 29: Wnt part ii 2013

Sample & Assay Technologies

Check pathway activity with active ββββ-catenin and Wnt target gene PCR array

10%

FB

S

active beta-catenin

GAPDH

total beta-catenin

SF

SF

+wnt

10%

FB

S

SF

SF

+wnt

FHC 293H

FHC

293H

siRNASerum free

wnt3a

siRNASerum free

wnt3a

24 36 48h

57 69 72h24

RNA

RNA0

1

2

3

4

5

6

7

8

0 400 0 400

wnt3a (ng/ml)

fold

cha

nge

CTNNB1

c-myc

cyclin D1

fra-1

axin2

sox9

0

1

2

3

4

5

6

7

0 200 0 200

wnt3a (ng/ml)

fold

cha

nge

CTNNB1

c-myc

cyclin D1

fra-1

axin2

CCND2

293H

FHC

sinon siCTNNB1

Page 30: Wnt part ii 2013

Sample & Assay Technologies

Experiment problem and approach

Q: Why the effect of Wnt stimulation on FHC cells w as weaker than that on 293H cells?

Approach: Expression profiling of 293H and FHC cell s on Wnt pathway genes with Wnt Signaling Pathway PCR array.

Hypothesis: Defect in Wnt signaling pathway transdu ction in FHC cell?

Page 31: Wnt part ii 2013

Sample & Assay Technologies

Wnt pathway PCR Array

Signaling

Function

Page 32: Wnt part ii 2013

Sample & Assay Technologies

Differential expression of receptors and ligands in 293H vs FHC cell

293H vs FHC29

3H

FHC

FZD5FZD3

Wnt3Wnt5A

Page 33: Wnt part ii 2013

Sample & Assay Technologies

From microarray to PCR - Custom PCR array

TMEM2MYCFGFR3PODXLSMAD6CALM1TMED1ASB13LEF1FEZ2SKP2PGM1MRPL54DIMT1LSMAD3MKXSCD5MTSS1CA2CCND2LAPTM4BNAV2HSPA12ASORBS2C3orf31MT1AC5orf13AKT1MKKSMTP18DPM3ZAKILKWDR54DPYSL2CNTNAP2CHSY1ICKNEFLRPRMLPIGYMRFAP1FAM125BNUAK1CYP4V2HES5FTSJ1TMEM98GARNL4CCND1LOC653506HCFC1R1FAM44BCXADRIGFBP5TARBP2EYA2CERKPRMT6SH3D19PHBTHOC7REEP5FAM134B

+ – + –– – + +Wnt3a 400 ng/ml

siCTNNB1Custom PCR array

12 Genes8 Samples

24 Genes4 Samples

32 Genes3 Samples

48 Genes2 Samples

96 Genes1 Sample

0

1

2

3

4

5

6

7

8

0 400 0 400

wnt3a (ng/ml)

fold

cha

nge

CTNNB1

c-myc

cyclin D1

fra-1

axin2

sox9

293H

sinon siCTNNB1

Page 34: Wnt part ii 2013

Sample & Assay Technologies

Identify Wnt signature genes with Custom Wnt response gene PCR array

– +

U373MG

– +

MCF-7

– +

HT29

– +

LnCap

– +

HepG2

siCTNNB1

active CTNNB1

LiCl 20 uM

– + –CCD1079SK BJ U105MG

– +–– +– –

– +– –

Wnt3a 400 ng/ml

Lncap

– +– –

GAPDH

CTNNB1

GAPDH

Custom Wnt response gene PCR array

Page 35: Wnt part ii 2013

Sample & Assay Technologies

Interesting question during experiment

Q: What’s the mechanism involved in differential Wnt target gene expression between HepG2 and IMR90 cells?

Approach: Examine methylation status of Wnt pathway transduction genes with Wnt signaling EpiTech Methyl qPCR array.

wnt3a

LEF1

YX

Hypothesis: Epigenetic silencing of Wnt pathway transducers in HepG2 cell?

Page 36: Wnt part ii 2013

Sample & Assay Technologies

EpiTech Methyl qPCR Array Protocol Overview

(0.5 – 4 ug of Genomic DNA)

Raw CtValues

Innovative technology enabling fast and accurate de tection of CpG island DNA methylation of individual genes, and disease or pathway focused gene panels

Page 37: Wnt part ii 2013

Sample & Assay Technologies

Differentially methylated genes identified by EpiTech Methyl qPCR Wnt signaling array

HepG2

IMR90

Unmethylated

Methylated

Unmethylated

Methylated

0

10

20

30

40

50

60

70

80

90

100

FZD1 FZD2 FZD9 SOX17 WIF1

% T

otal

inpu

t DN

A

0

10

20

30

40

50

60

70

80

90

100

FZD1 FZD2 FZD9 SOX17 WIF1

% T

otal

inpu

t DN

A

Page 38: Wnt part ii 2013

Sample & Assay Technologies

Sixteen genes were identified as Wnt signature genes

Pro

babi

lity

of p

athw

ay a

ctiv

atio

n

Page 39: Wnt part ii 2013

Sample & Assay Technologies

Sensitivity of Wnt signature genes

Active- ββββ-catenin

GAPDH

0 1.25 2.5 5 10

HCT116 (CCT036477, 6h)

20 µµµµM 0 1.25 2.5 5 10

293H (CHIR99021, 24h)

20 µµµµM

Pathway activity based on Wnt gene signature

Page 40: Wnt part ii 2013

Sample & Assay Technologies

Summary

� Overview of Wnt signaling� Wnt discovery and family members� Canonical - β-catenin� Nonncanonical – Wnt/JNK & Wnt/Ca2+

� Function of Wnt signaling� Development – many aspects� Tissue homeostasis – maintain stem cell like feature� Pathological condition – cancer, bone, nervous

� Wnt gene signature development with various tools – A gene expression signature to measure Wnt pathway activity� PCR array – study gene expression changes related to Wnt signaling� siRNA – gene silencing for functional Wnt pathway study� EpiTech Methyl array – explore mechanism of gene expression changes� Cignal Reporter assay – assess pathway activity of Wnt signaling

Page 41: Wnt part ii 2013

Sample & Assay Technologies

Additional Resources

E-Learning Center:Recorded Seminars

Questions?Contact Technical Support 9 AM – 6 PM Eastern M – FContact: 1-888-503-3187 OR [email protected]